Aquilo Capital Management as of June 30, 2018
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 14 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 23.4 | $29M | 1.3M | 22.76 | |
| Loxo Oncology | 18.1 | $22M | 127k | 173.48 | |
| Cytomx Therapeutics (CTMX) | 12.2 | $15M | 650k | 22.86 | |
| Aduro Biotech | 11.6 | $14M | 2.0M | 7.00 | |
| Pieris Pharmaceuticals (PIRS) | 8.2 | $10M | 2.0M | 5.07 | |
| Fate Therapeutics (FATE) | 5.4 | $6.6M | 580k | 11.34 | |
| Spero Therapeutics (SPRO) | 5.0 | $6.1M | 417k | 14.67 | |
| Galapagos Nv- (GLPG) | 5.0 | $6.1M | 66k | 92.17 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 3.3 | $4.0M | 150k | 26.79 | |
| Cellectis S A (CLLS) | 2.8 | $3.4M | 119k | 28.28 | |
| Synlogic | 2.5 | $3.0M | 307k | 9.83 | |
| SPDR S&P Biotech (XBI) | 1.4 | $1.7M | 600k | 2.88 | |
| Five Prime Therapeutics | 0.8 | $1.0M | 65k | 15.80 | |
| Morphosys (MOR) | 0.2 | $303k | 10k | 30.30 |
